Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MGK_2's Profile
Displaying 151-200 of 888 result(s).
CYDY CytoDyn Inc
05/24/2024 7:16:37 PM
one could only hope Jake, but any t (1)
CYDY CytoDyn Inc
05/24/2024 6:47:27 PM
A single arm for leronlimab would n (1)
CYDY CytoDyn Inc
05/24/2024 7:21:29 AM
ohm, I apologize if this has alread (6)
CYDY CytoDyn Inc
05/19/2024 7:08:47 PM
i appreciate what you're saying if (13)
CYDY CytoDyn Inc
05/19/2024 7:00:25 PM
thanks ohm, is the reason it wouldn (5)
CYDY CytoDyn Inc
05/19/2024 4:29:02 PM
Yes, of course, Sean, but I had to (3)
CYDY CytoDyn Inc
05/19/2024 4:13:23 PM
Except of course, until David has h (2)
CYDY CytoDyn Inc
05/19/2024 4:09:32 PM
I believe the data could be sold. I (1)
CYDY CytoDyn Inc
05/19/2024 3:54:50 PM
Unsure why you believe nobody is re (8)
CYDY CytoDyn Inc
05/19/2024 11:53:46 AM
Given that Keytruda is the Darling (7)
CYDY CytoDyn Inc
05/19/2024 11:29:24 AM
Thanks Doc, but to some, it sums up (4)
CYDY CytoDyn Inc
05/19/2024 11:17:57 AM
Ingenious Answer (2)
CYDY CytoDyn Inc
05/19/2024 10:44:29 AM
Maybe Merck wanted the Phase II ful (10)
CYDY CytoDyn Inc
05/19/2024 8:23:29 AM
sorry ohm, let me make a better rep (4)
CYDY CytoDyn Inc
05/19/2024 7:35:58 AM
(5)
CYDY CytoDyn Inc
05/19/2024 6:36:51 AM
not according to biloxi
CYDY CytoDyn Inc
05/18/2024 6:35:37 PM
Maybe not directly from NIH, but ho (4)
CYDY CytoDyn Inc
05/18/2024 6:21:07 PM
Thanks Jake, yes, it does take some (6)
CYDY CytoDyn Inc
05/18/2024 12:47:07 PM
u/Upwithstock aka MLAB laid out his
CYDY CytoDyn Inc
05/18/2024 11:02:30 AM
Thanks Katangolo Search GSK in the
CYDY CytoDyn Inc
05/18/2024 9:41:08 AM
From the (3)
CYDY CytoDyn Inc
05/18/2024 9:07:16 AM
(8)
CYDY CytoDyn Inc
05/17/2024 8:20:07 PM
(11)
CYDY CytoDyn Inc
05/17/2024 7:52:33 PM
(14)
CYDY CytoDyn Inc
05/17/2024 8:23:34 AM
https://preview.redd.it/no-comprom (21)
CYDY CytoDyn Inc
05/17/2024 6:43:12 AM
Thank you so much jfl97. I apprecia (8)
CYDY CytoDyn Inc
05/16/2024 7:57:05 PM
this was posted 2/4/2024 (13)
CYDY CytoDyn Inc
05/06/2024 7:09:56 AM
I appreciate the private chat, but
CYDY CytoDyn Inc
05/05/2024 7:33:24 PM
Well, in the case of a cancer that (8)
CYDY CytoDyn Inc
05/05/2024 5:17:14 PM
I think you're referring to the res
CYDY CytoDyn Inc
05/03/2024 3:57:02 AM
Well along those lines, why stop at (5)
CYDY CytoDyn Inc
05/02/2024 5:53:35 PM
Preparing for the last ba (5)
CYDY CytoDyn Inc
05/02/2024 1:31:56 AM
Well said Figgs I'd suspect, they'r (3)
CYDY CytoDyn Inc
05/01/2024 4:53:58 AM
What about Astra Zeneca (2)
CYDY CytoDyn Inc
04/30/2024 10:30:31 PM
I'm referring to the comment string
CYDY CytoDyn Inc
04/29/2024 8:23:41 PM
When there are no answers, you pose (2)
CYDY CytoDyn Inc
04/28/2024 7:39:18 PM
of course it was. i'm not denying t (1)
CYDY CytoDyn Inc
04/28/2024 12:26:07 PM
Here it is copied and pasted: Nine
CYDY CytoDyn Inc
04/28/2024 10:56:19 AM
Well, they have everything necessar (1)
CYDY CytoDyn Inc
04/28/2024 6:44:53 AM
(1)
CYDY CytoDyn Inc
04/28/2024 6:39:17 AM
Dr. Kazempour began his career as a (1)
CYDY CytoDyn Inc
04/28/2024 6:17:30 AM
Precisely, to the FDA, leronlimab s (2)
CYDY CytoDyn Inc
04/28/2024 6:00:26 AM
it is what it is. deal with it. are (2)
CYDY CytoDyn Inc
04/27/2024 9:16:42 PM
If leronlimab was absorbable via th (3)
CYDY CytoDyn Inc
04/27/2024 9:08:58 PM
This is all conjecture, but how clo (2)
CYDY CytoDyn Inc
04/27/2024 8:51:03 PM
The best "non-pharma" candidate for (2)
CYDY CytoDyn Inc
04/27/2024 8:46:06 PM
Aka: patents. And that troglodyte k (3)
CYDY CytoDyn Inc
04/26/2024 8:12:31 AM
Savor the Sweetness of It https://w (7)
CYDY CytoDyn Inc
04/22/2024 7:34:17 AM
Withstanding the blip problem I’m
CYDY CytoDyn Inc
04/22/2024 7:32:05 AM
I’d say HIV would have near zero (2)
Go to page:
  • << First
  • < Previous
  • 3
  • 4
  • Next >

Recent Articles

  • US and China Seek Trade Solutions Amid Tariff Tensions
  • Introducing Automate's Push PRO: Revolutionary Shade Control
  • Exciting Esports World Cup Promotion from JBO Thailand
  • Harbour BioMed Unveils Strong Profit Predictions for Future Growth
  • Ascletis Begins Significant Obesity Study with ASC30 Drug
  • Elpis Biopharmaceuticals Partners with NCCS for Groundbreaking Research
  • Perseus Mining's Operational Highlights and Financial Overview
  • Shara Magomedov Shines at UFC Night with Epic Victory
  • Investors Urged to Participate in Class Action Against Centene
  • Exploring America’s Hidden Resource Potential and Technology
  • Trump's New Tariff Deal with EU: Impacts and Insights
  • Shaquille O'Neal's Hilarious Showdown with Jimmy Kimmel
  • Empowering Hims & Hers Health Shareholders: Your Legal Guide
  • Public Sentiment on Trump's Tax Cuts: A Closer Look
  • Innovative Cooling Solutions Pioneered by i2Cool for a Sustainable Future
  • Easterly ROCMuni Fund Class Action: Investor Rights Explained
  • Class Action Alert: RxSight Investors Take Action Against Losses
  • Investors of iRobot Corporation Urged to Act Before Deadline
  • Dustin Moskovitz Expands Asana Holdings with Major Purchase
  • Navigating High-Stress Careers: Insights from Executives
  • Banco Comercial Português Updates on Share Buy-Back Programme Activity
  • Centene Corporation Faces Class Action Over Investor Losses
  • Banco Comercial Português (BCP) Shares Buy-Back Program Update
  • Insights into Gilead Sciences, Inc. and Recent Developments
  • Legal Action Initiated Against Flywire Corporation's Officers
  • Replimune Group Faces Legal Action Amid Stock Price Decline
  • Investors Seek Clarity on Simulations Plus Financial Concerns
  • Shocking Survey: How Much Would You Sacrifice For Wealth?
  • Harnessing Natural Testosterone Boosters for Optimal Muscle Growth
  • Neuralink’s Recent Developments and Future Aspirations Explained
  • Global AI Cooperation: China's Vision for the Future of Technology
  • Investment Insights from Experts: Maximize Your $10,000 Now
  • Shiba Inu's 3,000% Growth Potential in Competitive Memecoin Market
  • Investors Seek Justice in Biohaven Ltd. Class Action Lawsuit
  • Class Action Lawsuit Against Hims & Hers Health, Inc. Explained
  • Sarepta Therapeutics Faces Legal Challenges Amidst Controversies
  • Investors Take Note: Class Actions Against Western Asset Management
  • Mereo BioPharma Faces Scrutiny as Investigation Unfolds
  • Centene Corporation Faces Class Action Lawsuit Amidst Losses
  • Investigation Unfolds for Capricor Therapeutics Amid Stock Fluctuations
  • KouShiCare Revolutionizes Dry Eye Treatment with LuminEyes
  • Philanthropic Impact of the Erb Family Foundation on Alzheimer's
  • Celebrating Innovation in Alzheimer’s Research: Awards Announcement
  • Investing in People: A Path to Prosperity and Growth in China
  • New Yorkers Discover the Essence of Shanghai's Culture
  • Bill Gates' Porsche 959 Saga: A 13-Year Journey to Freedom
  • Building Stronger Economic Connections Between China and the US
  • Discovering the Top Large Cap Stocks: Growth and Potential
  • Recent Class Action Lawsuit Filed Against iRobot Corporation
  • 3D Systems Faces Class Action Lawsuit Amid Financial Concerns
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site